ID

16009

Beschreibung

Navelbine and Capecitabine in the Treatment of Metastatic Breast Cancer; ODM derived from: https://clinicaltrials.gov/show/NCT00153907

Link

https://clinicaltrials.gov/show/NCT00153907

Stichworte

  1. 02.05.16 02.05.16 -
  2. 26.06.16 26.06.16 -
Hochgeladen am

26. Juni 2016

DOI

Für eine Beantragung loggen Sie sich ein.

Lizenz

Creative Commons BY 4.0

Modell Kommentare :

Hier können Sie das Modell kommentieren. Über die Sprechblasen an den Itemgruppen und Items können Sie diese spezifisch kommentieren.

Itemgroup Kommentare für :

Item Kommentare für :

Um Formulare herunterzuladen müssen Sie angemeldet sein. Bitte loggen Sie sich ein oder registrieren Sie sich kostenlos.

Eligibility Breast Cancer NCT00153907

Eligibility Breast Cancer NCT00153907

Inclusion Criteria
Beschreibung

Inclusion Criteria

Alias
UMLS CUI
C1512693
histologically confirmed breast cancer with evidence of locally advanced or metastatic disease
Beschreibung

locally advanced breast cancer

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0678222
UMLS CUI [1,2]
C0027627
female patients age 18 or older
Beschreibung

female and aged over 18

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0079399
UMLS CUI [1,2]
C0001779
no more than three prior chemotherapeutic regimens in the metastatic setting
Beschreibung

prior chemotherapeutic regimens

Datentyp

boolean

Alias
UMLS CUI [1]
C0392920
anc > 1,500/mm3
Beschreibung

neutrophil count

Datentyp

boolean

Alias
UMLS CUI [1]
C0948762
platelet count > 100,000/mm3
Beschreibung

platelet count

Datentyp

boolean

Alias
UMLS CUI [1]
C0005821
sgot < 3 x uln
Beschreibung

GOT

Datentyp

boolean

Alias
UMLS CUI [1]
C0201899
bilirubin < 1.5 x uln
Beschreibung

bilirubin

Datentyp

boolean

Alias
UMLS CUI [1]
C1278039
performance status of 0 or 1
Beschreibung

ECOG performance status

Datentyp

boolean

Alias
UMLS CUI [1]
C1520224
at least 3 weeks since prior chemotherapy or 2 weeks since prior radiation, surgery or any anticancer investigational agent
Beschreibung

interval since prior anticancer treatment

Datentyp

boolean

Alias
UMLS CUI [1,1]
C3541383
UMLS CUI [1,2]
C0920425
able to swallow and retain oral medications
Beschreibung

dysphagia

Datentyp

boolean

Alias
UMLS CUI [1]
C0500456
measurable disease
Beschreibung

measurable disease

Datentyp

boolean

Alias
UMLS CUI [1]
C1513041
Exclusion Criteria
Beschreibung

Exclusion Criteria

Alias
UMLS CUI
C0680251
prior vinca alkaloids
Beschreibung

prior therapy with vinca-alkaloids

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0042672
UMLS CUI [1,2]
C0392920
active gastrointestinal disease or disorder
Beschreibung

gastrointestinal disease

Datentyp

boolean

Alias
UMLS CUI [1]
C0017178
pregnant or lactating
Beschreibung

pregnant or lactating

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0032961
UMLS CUI [1,2]
C0006147
serious co-morbid medical or psychological condition
Beschreibung

serious comorbidities

Datentyp

boolean

Alias
UMLS CUI [1]
C0009488
prior bone marrow or stem cell transplant
Beschreibung

prior bone marrow or stem cell transplant

Datentyp

boolean

Alias
UMLS CUI [1]
C1504389
prior documented severe sensitivity to 5-fu
Beschreibung

hypersensitivity to fluorouracil

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0020517
UMLS CUI [1,2]
C0016360

Ähnliche Modelle

Eligibility Breast Cancer NCT00153907

Name
Typ
Description | Question | Decode (Coded Value)
Datentyp
Alias
Item Group
C1512693 (UMLS CUI)
locally advanced breast cancer
Item
histologically confirmed breast cancer with evidence of locally advanced or metastatic disease
boolean
C0678222 (UMLS CUI [1,1])
C0027627 (UMLS CUI [1,2])
female and aged over 18
Item
female patients age 18 or older
boolean
C0079399 (UMLS CUI [1,1])
C0001779 (UMLS CUI [1,2])
prior chemotherapeutic regimens
Item
no more than three prior chemotherapeutic regimens in the metastatic setting
boolean
C0392920 (UMLS CUI [1])
neutrophil count
Item
anc > 1,500/mm3
boolean
C0948762 (UMLS CUI [1])
platelet count
Item
platelet count > 100,000/mm3
boolean
C0005821 (UMLS CUI [1])
GOT
Item
sgot < 3 x uln
boolean
C0201899 (UMLS CUI [1])
bilirubin
Item
bilirubin < 1.5 x uln
boolean
C1278039 (UMLS CUI [1])
ECOG performance status
Item
performance status of 0 or 1
boolean
C1520224 (UMLS CUI [1])
interval since prior anticancer treatment
Item
at least 3 weeks since prior chemotherapy or 2 weeks since prior radiation, surgery or any anticancer investigational agent
boolean
C3541383 (UMLS CUI [1,1])
C0920425 (UMLS CUI [1,2])
dysphagia
Item
able to swallow and retain oral medications
boolean
C0500456 (UMLS CUI [1])
measurable disease
Item
measurable disease
boolean
C1513041 (UMLS CUI [1])
Item Group
C0680251 (UMLS CUI)
prior therapy with vinca-alkaloids
Item
prior vinca alkaloids
boolean
C0042672 (UMLS CUI [1,1])
C0392920 (UMLS CUI [1,2])
gastrointestinal disease
Item
active gastrointestinal disease or disorder
boolean
C0017178 (UMLS CUI [1])
pregnant or lactating
Item
pregnant or lactating
boolean
C0032961 (UMLS CUI [1,1])
C0006147 (UMLS CUI [1,2])
serious comorbidities
Item
serious co-morbid medical or psychological condition
boolean
C0009488 (UMLS CUI [1])
prior bone marrow or stem cell transplant
Item
prior bone marrow or stem cell transplant
boolean
C1504389 (UMLS CUI [1])
hypersensitivity to fluorouracil
Item
prior documented severe sensitivity to 5-fu
boolean
C0020517 (UMLS CUI [1,1])
C0016360 (UMLS CUI [1,2])

Benutzen Sie dieses Formular für Rückmeldungen, Fragen und Verbesserungsvorschläge.

Mit * gekennzeichnete Felder sind notwendig.

Benötigen Sie Hilfe bei der Suche? Um mehr Details zu erfahren und die Suche effektiver nutzen zu können schauen Sie sich doch das entsprechende Video auf unserer Tutorial Seite an.

Zum Video